Superiority of Frailty Over Age in Predicting Outcomes Among Clostridium Difficile Patients: Evidence from National Data.|https://dx.doi.org/10.1016/j.clinre.2024.102499
Gangrenous cholecystitis due to rare actinomyces odontolyticus infection in patient with pancreatic adenocarcinoma: A case report.|https://dx.doi.org/10.1016/j.idcr.2024.e02093
Distribution of Clostridioides difficile ribotypes and sequence types across humans, animals and food in thirteen European countries.|https://dx.doi.org/10.1080/22221751.2024.2427804
Bioengineered Probiotics for Clostridioides difficile Infection: An Overview of the Challenges and Potential for This New Treatment Approach.|https://dx.doi.org/10.1007/s12602-024-10398-x
Fecal Microbiota Transplantation: Indications, Methods, and Challenges.|https://dx.doi.org/10.1007/s12275-024-00184-3
Oral Capsule FMT Combined With Bezlotoxumab Is a Successful Rescue Protocol Following Failure of FMT Alone in the Treatment of Recurrent C. difficile Infection.|https://dx.doi.org/10.1097/MCG.0000000000002108
Protection against Clostridioides difficile disease by a naturally avirulent strain.|https://dx.doi.org/10.1016/j.chom.2024.11.003
Patient Satisfaction Scale Following a Laxative for Antibiotic Washout Prior to Oral Microbiome Therapy.|https://dx.doi.org/10.1007/s12325-024-03065-8
IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity.|https://dx.doi.org/10.1101/2024.11.16.623943
[Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study].|https://dx.doi.org/10.37201/req/086.2024
